Vegf-based vaccine for modulating tumor microenvironment
A VEGF-targeting vaccine, HEBERSaVax, aims to modulate the tumor microenvironment by inducing immune responses against excess VEGF, enhancing other immune therapies in cancer treatment. It has shown promising results in ...